Outcomes of patients (pts) treated with novel immunotherapy (IT) agents in phase 1 clinical trials (Ph1-CT) at early lines for advanced disease

Juan Jose Soto, Carlos Erasun Lecuona,Sandra Llop Serna, Nuria Mulet Margalef,Agostina Stradella,Rafael Villanueva, Mariona Calvo Campos, Maria Jove Casulleras,Carmen Cuadra Amor, Ramon Salazar Soler,Marta Gil-Martin,Juan Martin-Liberal,Marc Oliva

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 0|浏览1
暂无评分
关键词
novel immunotherapy,clinical trials,advanced disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要